Table of contents
November 2015 - Volume 86 - 11
- Editorial commentaries
- Amyotrophic lateral sclerosis
- Neuromuscular
- Multiple sclerosis
- Movement disorders
- Cognitive neurology
- Neurodegeneration
- General neurology
- Migraine
- Cerebrovascular disease
- Epilepsy
- Neurological picture
- PostScript
- ABN abstracts 2015 ABN Annual Meeting, 10 September 2015, Institute of Education, London
Amyotrophic lateral sclerosis
Neuromuscular
- Review: Nodopathies of the peripheral nerve: an emerging concept (19 February, 2015)
Multiple sclerosis
Movement disorders
Cognitive neurology
Neurodegeneration
General neurology
Migraine
Cerebrovascular disease
Epilepsy
Neurological picture
PostScript
- Letter: Variant Creutzfeldt-Jakob disease in older patients (21 January, 2015)
ABN abstracts 2015 ABN Annual Meeting, 10 September 2015, Institute of Education, London
- 004: ANALYSIS OF CONVULSIVE SEIZURES AT A DGH EMERGENCY DEPARTMENT (14 October, 2015)
- 005: DOES UNDERSTANDING BASIC NEUROSCIENCE CURE NEUROPHOBIA? (14 October, 2015)
- 007: THE SPECTRUM OF MIGRAINE IN 306 PATIENTS WITH CADASIL (14 October, 2015)
- 008: CHARACTERISTICS OF FUNCTIONAL AND ORGANIC STROKE MIMICS (14 October, 2015)
- 009: THE KNOWN UK CASES OF ATAXIA TELANGIECTASIA-LIKE DISORDER (ATLD) (14 October, 2015)
- 010: OCULAR MG IN 101 CASES: TOWARDS A RISK OF GENERALISATION (‘ROG’) SCORE (14 October, 2015)
- 013: ABNORMAL PAIN AND TEMPERATURE PROCESSING IN DEMENTIA (14 October, 2015)
- 014: ZEBRAFISH AS A MODEL OF GLUCOCEREBROSIDASE 1 (GBA1) DEFICIENCY (14 October, 2015)
- 015: GENE SET ENRICHMENT ANALYSIS IN AMYOTROPHIC LATERAL SCLEROSIS (14 October, 2015)
- 016: A GENOME-WIDE ASSOCIATION STUDY IN PROGRESSIVE SUPRANUCLEAR PALSY (14 October, 2015)
- 020: A NEURAL BIOMARKER FOR CHRONIC PAIN BASED ON DECODED BRAIN NETWORKS (14 October, 2015)
- 021: A SENSE OF DIRECTION: BRAIN STIMULATION IN LATERALISED BRAIN FUNCTION (14 October, 2015)
- 022: SLEEP AND CIRCADIAN RHYTHM REGULATION IN EARLY PARKINSON'S DISEASE (14 October, 2015)
- 025: FIRST CASE SERIES OF VENOUS SINUS STENTING IN IIH PATIENTS IN WALES (14 October, 2015)
- 028: AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANT IN MS: SHEFFIELD COHORT (14 October, 2015)
- 029: DISEASE MODIFYING TREATMENTS IN MS: INDUCTION OR ESCALATION? (14 October, 2015)
- 032: BED PARTNER ‘GAS-LIGHTING’ AS A CAUSE OF FICTITIOUS SLEEP-TALKING (14 October, 2015)
- 034: TABES DORSALIS IN THE POST ANTIBIOTIC ERA: NEVER SAY NEVER (14 October, 2015)
- 035: MOTOR NEURON DISEASE: A CASE OF MISGUIDED THERAPEUTIC NIHILISM (14 October, 2015)
- 036: STIFF PERSON SYNDROME PRESENTING AS ‘STIFF EYES’ (14 October, 2015)
- 037: ONE YEAR RETROSPECTIVE AUDIT OF CNS MALIGNANCY 2 WW REFERRALS (14 October, 2015)
- 039: ARE FEMALE ACADEMIC NEUROLOGISTS GETTING THEIR VOICES HEARD? (14 October, 2015)
- 040: A FRAMEWORK FOR MANAGING AND MONITORING NEUROLOGY REFERRALS (14 October, 2015)
- 042: WHY NEUROLOGY? THE CAREER CHOICES OF CURRENT UK NEUROLOGY TRAINEES (14 October, 2015)
- 043: ULTRASOUND ASSISTED LUMBAR PUNCTURE; THE NOT-SO-STEEP LEARNING CURVE (14 October, 2015)
- 044: USING NHS PRIMARY CARE DATA TO IDENTIFY UNDIAGNOSED DEMENTIA (14 October, 2015)
- 045: DURAL AVF CAUSING A TREATABLE CJD LIKE COGNITIVE DYSFUNCTION (14 October, 2015)
- 047: CONFUSION IN CLINICAL TRIALS OF ALZHEIMER'S DISEASE (14 October, 2015)
- 048: DEMENTIA AND THE ‘COCKTAIL PARTY’ PROBLEM (14 October, 2015)
- 049: MINI-ADDENBROOKE'S COGNITIVE EXAMINATION (M-ACE): PRAGMATIC STUDY (14 October, 2015)
- 052: SAFETY AND EFFICACY OF ESLICARBAZEPINE ACETATE IN ELDERLY PATIENTS (14 October, 2015)
- 054: ADJUNCTIVE PERAMPANEL RCT FOR PGTC SEIZURES (14 October, 2015)
- 055: FYDATA STUDY: PERAMPANEL STUDY IN A REAL-LIFE SETTING (14 October, 2015)
- 060: SCREENING FOR DEMENTIA: IS 1 SIMPLE QUESTION THE ANSWER? (14 October, 2015)
- 062: A NOVEL LGI1 VARIANT IN LATERAL TEMPORAL LOBE EPILEPSY (14 October, 2015)
- 063: THE INSULA: ISLAND OF REIL (14 October, 2015)
- 064: FRONT DOOR NEUROLOGY: THE GP EXPERIENCE (14 October, 2015)
- 067: WHAT IS THE NIN, AND WHAT CAN IT DO FOR YOU? (14 October, 2015)
- 068: WHAT IS THE NIN TELLING US? (14 October, 2015)
- 071: CLINICAL MANIFESTATIONS OF DNMT1 MUTATIONS (14 October, 2015)
- 073: MITOCHONDRIAL CYTOPATHY PRESENTING WITH CEREBELLAR ATAXIA (14 October, 2015)
- 074: URINARY, BOWEL AND SEXUAL FUNCTION IN PATIENTS WITH FRIEDREICH'S ATAXIA (14 October, 2015)
- 075: DURAL AVM AS A CAUSE OF RAISED PRESSURE SYMPTOMS IN TREATED CVST (14 October, 2015)
- 076: CASE REPORT: POURFOUR DU PETIT SYNDROME IN A PATIENT WITH MIGRAINE (14 October, 2015)
- 077: HEADACHE IN MILLER-FISHER SYNDROME (14 October, 2015)
- 079: DELAYED DIAGNOSIS OF CADASIL IN A PATIENT WITH HEMIPLEGIC MIGRAINE (14 October, 2015)
- 080: FLUNARIZINE IN PRIMARY HEADACHE DISORDERS (14 October, 2015)
- 082: THE MANAGEMENT OF MIGRAINE IN PRIMARY CARE (14 October, 2015)
- 084: OCCIPITAL NERVE BLOCK: AUDIT OF A DEVELOPING SERVICE (14 October, 2015)
- 085: TREATMENT OF NEUROLOGICAL MANIFESTATIONS OF SJOGREN'S SYNDROME (14 October, 2015)
- 086: AUTOIMMUNE RETINOPATHY – IMPORTANCE OF RECOVERIN B ANTIBODIES (14 October, 2015)
- 088: MANAGEMENT OF SUSPECTED ENCEPHALITIS IN A UK TEACHING HOSPITAL (14 October, 2015)
- 090: PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY: AN ATYPICAL CASE (14 October, 2015)
- 091: SPORADIC CREUTZFELDT-JAKOB DISEASE PRESENTING WITH A ‘JERKY ALIEN LIMB’ (14 October, 2015)
- 092: DIGGING DEEPER (14 October, 2015)
- 093: LPS INDUCES AGGREGATION OF α-SYNUCLEIN IN MONOCYTES (14 October, 2015)
- 094: iPAD-BASED ASSESSMENT IN PARKINSON'S DISEASE (14 October, 2015)
- 095: PARKINSON'S DISEASE AND SPIRITUALITY (14 October, 2015)
- 096: ECG ABNORMALITIES IN ALTERNATING HEMIPLEGIA: A BROADENED PHENOTYPE (14 October, 2015)
- 097: IS THE APPLAUSE SIGN USEFUL FOR DIAGNOSIS OF DEMENTIA AND MCI? (14 October, 2015)
- 098: CONSTIPATION PRECEDING PARKINSON'S DISEASE–META-ANALYSIS (14 October, 2015)
- 099: DISCRIMINATION IN DYSTONIA: TIME FOR A RETHINK? (14 October, 2015)
- 100: ETHNICITY AND MULTIPLE SCLEROSIS PREVALENCE IN EAST LONDON (14 October, 2015)
- 102: REDUCED MS RELAPSE RATES WITH NATALIZUMAB: TOP UK COHORT (14 October, 2015)
- 103: THE PROFILE OF MULTIPLE SCLEROSIS IN GENERAL PRACTICE (14 October, 2015)
- 104: COGNITIVE REHABILITATION IN MULTIPLE SCLEROSIS (14 October, 2015)
- 106: ALEMTUZUMAB IMPROVES 3-YEAR QUALITY OF LIFE IN CARE-MS II (14 October, 2015)
- 107: SEASON OF GLANDULAR FEVER AS A RISK FACTOR FOR MULTIPLE SCLEROSIS (14 October, 2015)
- 110: THE PHYSICAL, SOCIAL & ECONOMIC EXTENT OF MULTIPLE SCLEROSIS IN SUSSEX (14 October, 2015)
- 112: PARTIAL INDEPENDENCE OF FINGOLIMOD EFFECT ON DIFFUSE VS. FOCAL DAMAGE (14 October, 2015)
- 113: MANAGEMENT OF FINGOLIMOD FIRST DOSE OBSERVATION (FDO) IN THE UK (14 October, 2015)
- 114: EFFECT OF FINGOLIMOD VS. IFN-BETA1A ON NO EVIDENCE OF DISEASE ACTIVITY (14 October, 2015)
- 115: SUSTAINED LOW RATE BRAIN VOLUME LOSS IN LONG TERM FINGOLIMOD TREATMENT (14 October, 2015)
- 117: ANTI-JCV TITRES INCREASE OVER TIME WITH NATALIZUMAB TREATMENT (14 October, 2015)
- 119: MANAGEMENT OF ADVERSE REACTIONS TO ALEMTUZUMAB INFUSION (14 October, 2015)
- 120: EFFECT OF TERIFLUNOMIDE ON LYMPHOCYTE AND NEUTROPHIL COUNTS (14 October, 2015)
- 121: SAFETY AND TOLERABILITY OF TERIFLUNOMIDE IN CLINICAL STUDIES (14 October, 2015)
- 122: ANALYSIS OF THE TOPIC STUDY USING 2010 MCDONALD CRITERIA (14 October, 2015)
- 124: PSYCHOLOGICAL ATTRIBUTES AND WORK INSTABILITY IN MS (14 October, 2015)
- 125: DISEASE MODIFYING TREATMENT UTILISATION IN MULTIPLE SCLEROSIS (14 October, 2015)
- 127: PATIENT-REPORTED OUTCOMES AND DISABILITY IN MULTIPLE SCLEROSIS (14 October, 2015)
- 129: SUSAC'S SYNDROME: A CASE SERIES FROM A REGIONAL NEUROSCIENCES UNIT (14 October, 2015)
- 130: GLYCINE RECEPTOR ANTIBODY—A MARKER FOR NMO/ NON-MS DEMYELINATION? (14 October, 2015)
- 131: HASHIMOTO'S ENCEPHALOPATHY PRESENTING AS REFRACTORY HYPOTHERMIA (14 October, 2015)
- 135: PSYCHIATRIC PRESENTATIONS OF AUTOANTIBODY-MEDIATED ENCEPHALITIS (14 October, 2015)
- 136: CEREBRAL VASCULITIS HISTOPATHOLOGY IN RELAPSING POLYCHONDRITIS (14 October, 2015)
- 139: GOING BLIND ON DIALYSIS: NYCTALOPIA DUE TO TRANEXAMIC ACID (14 October, 2015)
- 141: SPINAL STENOSIS IN FAMILIAL TRANSTHYRETIN AMYLOIDOSIS (14 October, 2015)
- 143: UNUSUAL DECREMENTAL RESPONSE IN LAMBERT EATON MYASTHENIC SYNDROME (14 October, 2015)
- 145: AN AUDIT OF HOSPITALISATION IN MYASTHENIA GRAVIS PATIENTS (14 October, 2015)
- 148: TIMELINESS OF MOTOR NEURONE DISEASE CARE– DIAGNOSIS TO SERVICE ACCESS (14 October, 2015)
- 150: PARANEOPLASTIC NMO AND REVIEW OF MRI FINDINGS IN 18 NMO PATIENTS (14 October, 2015)
- 151: PERIPHERAL NERVE BING-NEEL SYNDROME (14 October, 2015)
- 152: THE NEUROPATHY SPECTRUM IN WALDENSTRöM'S MACROGLOBULINAEMIA (14 October, 2015)
- 154: CNS RELAPSE OF NHL MASQUERADING AS MILLER FISHER SYNDROME (14 October, 2015)
- 155: LUNG CANCER BRAIN METASTASES: FACTORS ENHANCING TUMOUR CELL ADHESION (14 October, 2015)
- 156: AUDIT OF CSF CYTOLOGY AT THE WEST MIDLANDS NEUROSCIENCE CENTRE (14 October, 2015)
- 157: RARE PARANEOPLASTIC POLYNEUROPATHY SECONDARY TO SKIN MELANOMA (14 October, 2015)
- 162: THE MANY FACES OF MELAS (14 October, 2015)
- 163: A SPASTIC ATAXIC GAIT WITH A BIT MORE BITE (14 October, 2015)
- 166: HOME COMPUTERISED COGNITIVE TESTING FOR TBI IS FEASIBLE AND POPULAR (14 October, 2015)
- 167: BILATERAL INTERNAL CAROTID ARTERY DISSECTION WITH CONFUSION (14 October, 2015)
- 170: IMPACT & TREATMENT OF NON-MOTOR SYMPTOMS IN EARLY PARKINSON'S DISEASE (14 October, 2015)
- 171: VISUOSPATIAL TESTS TO SCREEN FOR IMPAIRED COGNITION IN PARKINSON'S (14 October, 2015)
- 172: THE RELATIONSHIP BETWEEN CLOCK DRAWING AND COGNITION IN PARKINSON'S (14 October, 2015)
- 173: FINGER TAPPING AND COGNITION IN PARKINSON'S (14 October, 2015)
- 174: FRACTURE RISK IN INCIDENT PARKINSONIAN COHORT VERSUS CONTROLS (14 October, 2015)
- 176: CO-MORBIDITY BURDEN IN PARKINSON'S DISEASE AND MATCHED CONTROLS (14 October, 2015)
- 177: PREDICTORS OF INSTITUTIONALISATION IN PARKINSON'S DISEASE (14 October, 2015)
- 178: MORTALITY IN PARKINSON'S DISEASE AND ATYPICAL PARKINSONIAN DISORDERS (14 October, 2015)
- 179: THE PREDICTIVE VALUE OF DIFFERENT MOTOR FEATURES IN PARKINSON'S (14 October, 2015)
- 181: REWARD SENSITIVITY DEFICITS UNDERLIE APATHY IN PARKINSON'S DISEASE (14 October, 2015)
- 182: MPP+ IN A ZEBRAFISH MODEL OF GLUCOCEREBROSIDASE 1 DEFICIENCY (14 October, 2015)
- 183: FEATURES IN IDIOPATHIC RBD MIRROR THOSE OBSERVED IN PD (14 October, 2015)
- 184: NEUROIMAGING OF IDIOPATHIC REM SLEEP BEHAVIOR DISORDER (14 October, 2015)
- 186: KNOWLEDGE OF PRESCRIBING IN PARKINSONISM AMONG JUNIOR DOCTORS (14 October, 2015)
- 188: THROMBOSED BRAINSTEM DEVELOPMENTAL VENOUS ANOMALY CAUSING HYDROCEPHALUS (14 October, 2015)
- 189: NETWORK DYSFUNCTION IN POST-STROKE APHASIA (14 October, 2015)
- 192: THE ZEBRA SIGN (14 October, 2015)
- 193: ORAL ANTICOAGULANT PRESCRIBING IN A HYPERACUTE STROKE UNIT (14 October, 2015)
Editorial commentaries